Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring.
Saved in:
| Title: | Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring. |
|---|---|
| Authors: | Santra, Mithun1 (AUTHOR), Geary, Moira L.1 (AUTHOR), Rubin, Elizabeth1 (AUTHOR), Hsu, Michael Y. S.2 (AUTHOR), Funderburgh, Martha L.1 (AUTHOR), Chandran, Christine1 (AUTHOR), Du, Yiqin3 (AUTHOR), Dhaliwal, Deepinder K.1 (AUTHOR), Jhanji, Vishal1 (AUTHOR), Yam, Gary Hin-Fai1,4,5 (AUTHOR) yamg@pitt.edu |
| Source: | Stem Cell Research & Therapy. 1/8/2024, Vol. 15 Issue 1, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
